Prescription drug development continues to increase in importance. In 2006, U.S. biopharmaceutical companies invested $56.1 billion in research and development of which $44.9 billion was conducted in the U.S.1 In 2008 alone, the U.S. Food & Drug Administration approved 24 new drugs.2 Pharmaceutical, biotechnology, chemical and healthcare companies are involved in the effort to identify new ...
Selecting the best possible packaging for your product is a real challenge: you need to find packaging that offers the right protection, with safe and easy handling, a smooth integration into your operation, that boosts your product's image and satisfies all quality requirements of your entire supply chain. This free White Paper offers valuable tips
A guideline for those involved in the selection, specification, and purchase of mixers
Mixing is possibly the oldest and most widely used of all technical processes. It is carried out in virtually every in handling or processing powders with other ingredients and there are very few products used in everyday life that have a mixing process as part of their manufacture. Mixing can therefore be ...
Drug innovators, collaborators, licensing partners and the myriad of third parties who handle active pharmaceutical ingredients (APIs) need to take notice when the APIs they are handling have the following properties – clinical doses less than 10 milligrams causing pharmacological or toxic effects in patients or if low doses (less than 1 mg/kg/day) in laboratory animals may potentially be ...
Potent and highly potent active pharmaceutical ingredients have the potential to cause serious health effects in workers at very low airborne concentrations. The use of containment equipment as part of a systematic approach to potent compound safety is advised to control worker exposure. However the containment performance of equipment can not be assumed, evaluation of containment performance, ...
Chemical caotegorization (or banding) of inherent toxicity and potency linked with defined engineering and work practice controls and personal protective equipment has become an integral component of assuring the health and safety of researchers and manufactruing personnel in the pharmaceutical industry.
Equipment qualification is a
necessary and critical step in
ensuring that a product or service
is provided accurately and
consistently with requirements
aligned with medical device
manufacturing and testing. This is
especially critical for the medical
device industry because the
medical device manufactured by a
company is considered a piece of equipment and requires qualification, as much as ...
Equipment qualification is a critical step in ensuring that a product or service is provided accurately and consistently with regards to manufacturing and testing. The time-saving attribute of adding prerequisites to a qualification program, along with the benefit of gaining the ability to track and trend problem areas, make the addition both worthwhile and costeffective.
Part 1 of Running a ...
Point Of Care Testing in Clinical Trials – Page 1
Point of care (POC) testing is diagnostic testing performed promptly and conveniently in the vicinity of the patient, avoiding the often lengthy procedure of sending samples to be processed in a central laboratory. This gives rise to the alternative names of near‐patient and bedside testing. The requirement for POC testing is increasing, with the ...
The MICROLAB® NIMBUS is Hamilton Company's newest automated multi-channel pipetting platform, offering a high density deck layout in a body small enough ...
Company descriptions and contact
information are quoted
from the company's website or other promotional information. JAZ'D is not responsible for
the accuracy
of this information. Unless specifically noted, JAZ'D is not sponsored by, affiliated with
or otherwise
connected with any of the listed companies.
